These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10342063)

  • 1. Possible mechanism underlying the efficacy of low dose cyclosporine in autoimmune diseases.
    Matsushita M; Takeda-Hirokawa N; Ogasawara H; Sugiyama M; Ando S; Sekigawa I; Iida N; Hashimoto H; Hirose S
    Clin Exp Rheumatol; 1999; 17(2):265-6. PubMed ID: 10342063
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose cyclosporin for multiple colonic ulcers associated with mixed connective tissue disease.
    Maeda N; Abe S; Yoshizawa T; Ogawa K; Sekigawa I; Iida N; Eguchi M; Matsumoto M; Hashimoto H; Hirose S
    Clin Rheumatol; 1999; 18(5):410-3. PubMed ID: 10524557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular disease in mixed connective tissue disease (MCTD).
    Kondo H
    Intern Med; 2001 Dec; 40(12):1176. PubMed ID: 11813839
    [No Abstract]   [Full Text] [Related]  

  • 4. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
    Dahl M; Chalmers A; Wade J; Calverley D; Munt B
    J Rheumatol; 1992 Nov; 19(11):1807-9. PubMed ID: 1491407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim CH; Choi YS; Cheong KA; Lee AY
    Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed connective tissue disease with multiple organ damage: successful treatment with plasmapheresis.
    Seguchi M; Soejima Y; Tateishi A; Iida H; Yamamoto M; Nakashima K; Murakami F; Ohashi S; Yamashita S; Maekawa T; Murashige A; Umemoto S; Matsuzaki M; Fukumoto Y
    Intern Med; 2000 Dec; 39(12):1119-22. PubMed ID: 11197805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease.
    Murakami M; Shimane K; Takahashi H; Tomiyama J; Nagashima M
    Mod Rheumatol; 2013 Jan; 23(1):156-61. PubMed ID: 22391860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decision on therapeutic course and follow-up study of collagen diseases].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1991 Nov; 80(11):1762-5. PubMed ID: 1783842
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension.
    Kamata Y; Nara H; Sato H; Masuyama JI; Minota S; Yoshio T
    Ann Rheum Dis; 2005 Aug; 64(8):1236-7. PubMed ID: 16014687
    [No Abstract]   [Full Text] [Related]  

  • 15. Airway cellular response to two different immunosuppressive regimens in lung transplant recipients.
    Slebos DJ; Kauffman HF; Koëter GH; Verschuuren EA; Bij W; Postma DS
    Clin Transplant; 2005 Apr; 19(2):243-9. PubMed ID: 15740562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mixed connective tissue disease in children].
    Villaseñor-Zepeda J; Vidales-Bayona C; Berrón-Pérez R; Santana-Mondragón R; Loredo-Abdalá A; Carbajal-Rodríguez L; Durán-Chávez C
    Bol Med Hosp Infant Mex; 1985 Dec; 42(12):725-34. PubMed ID: 4091945
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of peripheral blood leukocytes in patients with cyclosporine A-induced gingival hyperplasia.
    Cebeci I; Kantarci A; Gürel N; Adin S; Tuncer O; Carin M; Badur S; Firatli E
    J Periodontol; 1998 Dec; 69(12):1435-9. PubMed ID: 9926775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.